Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-007566
Filing Date
2017-02-03
Accepted
2017-02-03 16:06:43
Documents
1
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 5016
  Complete submission text file 0001209191-17-007566.txt   6447
Mailing Address 9050 CAMINO SANTA FE SAN DIEGO CA 92121
Business Address
HENSON HEIDI (Reporting) CIK: 0001283301 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-37620 | Film No.: 17572149

Mailing Address 11119 N. TORREY PINES ROAD, STE 125 LA JOLLA CA 92037
Business Address 11119 N. TORREY PINES ROAD, STE 125 LA JOLLA CA 92037 (858) 500-8800
Kura Oncology, Inc. (Issuer) CIK: 0001422143 (see all company filings)

EIN.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations